Benoı̂t Blanchet

5.2k citations

142 papers · 3.7k · h-index 36

Impact in

Transplantation top 2%
- Renal Transplantation Outcomes and Treatments
Oncology top 5%
- Cancer Immunotherapy and Biomarkers

Papers in

Oncology 53
- Colorectal Cancer Treatments and Studies 18
- Cancer Treatment and Pharmacology 13
- Cancer Immunotherapy and Biomarkers 10
Pulmonary and Respiratory Medicine 42
- Renal cell carcinoma treatment 14
- Lung Cancer Treatments and Mutations 11
- Prostate Cancer Treatment and Research 8

Co-authors: François Goldwasser (67 shared papers)Michel Vidal (49 shared papers)Pascaline Boudou‐Rouquette (39 shared papers)Michel Tod (21 shared papers)Romain Coriat (20 shared papers)Stanislas Ropert (15 shared papers)Olivier Mir (18 shared papers)Audrey Thomas‐Schoemann (44 shared papers)
Journals: Investigational New Drugs (9 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (8 papers)Journal of Pharmaceutical and Biomedical Analysis (7 papers)Journal of Chromatography B (6 papers)
Partner nations: France United States Switzerland

In The Last Decade

Benoı̂t Blanchet

135 papers receiving 3.6k citations

Peers

Countries citing papers authored by Benoı̂t Blanchet

Since Specialization

Citations

This map shows the geographic impact of Benoı̂t Blanchet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoı̂t Blanchet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoı̂t Blanchet more than expected).

Fields of papers citing papers by Benoı̂t Blanchet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoı̂t Blanchet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoı̂t Blanchet. The network helps show where Benoı̂t Blanchet may publish in the future.

Co-authors

The 25 scholars most cited alongside Benoı̂t Blanchet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Benoı̂t Blanchet Line = papers co-authored together Benoı̂t Blanchet links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma PLoS ONE ·Olivier Mir, Romain Coriat, Benoı̂t Blanchet, Jean-Philippe Durand, Pascaline Boudou‐Rouquette, Judith Michels, Stanislas Ropert, Michel Vidal, Stanislas Pol, Stanislas Chaussade, François Goldwasser	2012	244
2	Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes Circulation ·Jean‐Philippe Collet, Gilles Montalescot, Benoı̂t Blanchet, Marie‐Laure Tanguy, J.-L. Golmard, Rémi Choussat, Farzin Beygui, Laurent Payot, Nicolas Vignolles, J Metzger, Daniel Thomas	2004	241
3	Influence of Burns on Pharmacokinetics and Pharmacodynamics of Drugs Used in the Care of Burn Patients Clinical Pharmacokinetics ·Benoı̂t Blanchet, Vincent Jullien, Christophe Vinsonneau, Michel Tod	2008	119
4	Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice Journal of Pharmaceutical and Biomedical Analysis ·Benoı̂t Blanchet, Bertrand Billemont, Julie Cramard, Anne Sophie Benichou, Stéphanie Chhun, Laura Harcouët, Stanislas Ropert, A. Dauphin, François Goldwasser, Michel Tod	2009	106
5	Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study Cancers ·Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux‐Leprieur, Elizabeth Fabre, Marie Wislez, Marco Alifano, Karen Leroy, Pascaline Boudou‐Rouquette, Camille Tlemsani, Nihel Khoudour, Jennifer Arrondeau, Audrey Thomas‐Schoemann, Hélène Blons, Audrey Mansuet‐Lupo, Diane Damotte, Michel Vidal, François Goldwasser, Jérôme Alexandre, Benoı̂t Blanchet	2020	93
6	Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib Clinical Pharmacokinetics ·Alicja Puszkiel, Gaëlle Noé, Audrey Bellesœur, N. Kramkimel, Marie‐Noëlle Paludetto, Audrey Thomas‐Schoemann, Michel Vidal, François Goldwasser, Étienne Chatelut, Benoı̂t Blanchet	2018	89
7	Early Sorafenib-Induced Toxicity Is Associated with Drug Exposure and UGTIA9 Genetic Polymorphism in Patients with Solid Tumors: A Preliminary Study PLoS ONE ·Pascaline Boudou‐Rouquette, Céline Narjoz, Jean Louis Golmard, Audrey Thomas‐Schoemann, Olivier Mir, Fabrice Taïeb, Jean-Philippe Durand, Romain Coriat, Alain Dauphin, Michel Vidal, Michel Tod, Marie‐Anne Loriot, François Goldwasser, Benoı̂t Blanchet	2012	87
8	Variability of Sorafenib Toxicity and Exposure over Time: A Pharmacokinetic/Pharmacodynamic Analysis The Oncologist ·Pascaline Boudou‐Rouquette, Stanislas Ropert, Olivier Mir, Romain Coriat, Bertrand Billemont, Michel Tod, Laure Cabanes, Nathalie Franck, Benoı̂t Blanchet, François Goldwasser	2012	87
9	Sorafenib exposure decreases over time in patients with hepatocellular carcinoma Investigational New Drugs ·Jennifer Arrondeau, Olivier Mir, Pascaline Boudou‐Rouquette, Romain Coriat, Stanislas Ropert, Guillaume Dumas, Manuel Rodrigues, Benoı̂t Rousseau, Benoı̂t Blanchet, François Goldwasser	2011	86
10	Drug interactions with solid tumour-targeted therapies Critical Reviews in Oncology/Hematology ·Audrey Thomas‐Schoemann, Benoı̂t Blanchet, Christophe Bardin, Gaëlle Noé, Pascaline Boudou‐Rouquette, Michel Vidal, François Goldwasser	2013	81
11	Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients Investigational New Drugs ·Valentine Heidelberger, François Goldwasser, N. Kramkimel, Anne Jouinot, Olivier Huillard, Pascaline Boudou‐Rouquette, J. Chanal, Jennifer Arrondeau, Nathalie Franck, Jérôme Alexandre, Benoı̂t Blanchet, Karen Leroy, Marie‐Françoise Avril, N. Dupin, S. Aractingi	2017	75
12	A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasma Journal of Chromatography B ·Lionel Faivre, Charline Gomo, Olivier Mir, Fabrice Taïeb, Audrey Schoemann-Thomas, Stanislas Ropert, Michel Vidal, Daniel Dusser, Alain Dauphin, François Goldwasser, Benoı̂t Blanchet	2011	70
13	Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection Journal of Chromatography B ·Tiphaine Legrand, Stéphanie Chhun, Elisabeth Rey, Benoı̂t Blanchet, J ZAHAR, Fanny Lanternier, Gérard Pons, Vincent Jullien	2008	69
14	Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors Blood ·Stéphane Giraudier, Hédia Chagraoui, Emiko Komura, Stéphane Barnache, Benoı̂t Blanchet, Jean Pierre LeCouédic, David F. Smith, Frédéric Larbret, Anne‐Laure Taksin, Françoise Moreau-Gachelin, Nicole Casadevall, Michel Tulliez, Anne Hulin, Najet Debili, William Vainchenker	2002	68
15	Leptospira exposure in the human environment in France: A survey in feral rodents and in fresh water Comparative Immunology Microbiology and Infectious Diseases ·Florence Aviat, B. Blanchard, Virginie Michel, Benoı̂t Blanchet, C. Branger, Jean Hars, François Mansotte, Lucien Brasme, Christophe de Champs, P. Bolut, P. Mondot, J. Faliu, S. Rochereau, Angéli Kodjo, G. André‐Fontaine	2008	64
16	Mechanically-induced aggregation of the monoclonal antibody cetuximab Annales Pharmaceutiques Françaises ·A. Lahlou, Benoı̂t Blanchet, Manuela Montenegro Dias de Carvalho, Muriel Paul, A. Astier	2009	61
17	Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasma Clinica Chimica Acta ·Benoı̂t Blanchet, Carole Saboureau, Anne Sophie Benichou, Bertrand Billemont, Fabrice Taïeb, Stanislas Ropert, Alain Dauphin, François Goldwasser, Michel Tod	2009	57
18	Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib PLoS ONE ·Romain Coriat, H. Gouya, Olivier Mir, Stanislas Ropert, O. Vignaux, Stanislas Chaussade, Philippe Sogni, Stanislas Pol, Benoı̂t Blanchet, P. Legmann, François Goldwasser	2011	56
19	Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients Journal of Pharmaceutical and Biomedical Analysis ·Rafael Reis, Laurence Labat, Marie Allard, Pascaline Boudou‐Rouquette, Jeanne Chapron, Audrey Bellesœur, Audrey Thomas‐Schoemann, Jennifer Arrondeau, Frédérique Giraud, Jérôme Alexandre, Michel Vidal, François Goldwasser, Benoı̂t Blanchet	2018	56
20	Pneumatosis intestinalis associated with treatment of cancer patients with the vascular growth factor receptor tyrosine kinase inhibitors sorafenib and sunitinib Investigational New Drugs ·Romain Coriat, Stanislas Ropert, Olivier Mir, Bertrand Billemont, Stanislas Chaussade, Pierre‐Philippe Massault, Benoı̂t Blanchet, O. Vignaux, François Goldwasser	2010	52

About Benoı̂t Blanchet

Benoı̂t Blanchet is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Transplantation, having authored 142 papers that have together received 3.7k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (18 papers), Renal cell carcinoma treatment (14 papers), Cancer Treatment and Pharmacology (13 papers), Renal Transplantation Outcomes and Treatments (12 papers), Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Melanoma and MAPK Pathways (10 papers) and Prostate Cancer Treatment and Research (8 papers). The work is most often cited by research in Transplantation (206 citations), Oncology (833 citations), Hepatology (228 citations), Hematology (294 citations) and Internal Medicine (84 citations). Benoı̂t Blanchet has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include François Goldwasser, Michel Vidal, Pascaline Boudou‐Rouquette, Michel Tod, Romain Coriat, Stanislas Ropert, Olivier Mir, Audrey Thomas‐Schoemann, Bertrand Billemont and François Goldwasser. Their work appears in journals such as Investigational New Drugs, Journal of Clinical Oncology, Annals of Oncology, Journal of Pharmaceutical and Biomedical Analysis and Journal of Chromatography B.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Benoı̂t Blanchet

Impact in

Papers in i

In The Last Decade

Benoı̂t Blanchet

Peers

Countries citing papers authored by Benoı̂t Blanchet

Fields of papers citing papers by Benoı̂t Blanchet

All Works

About Benoı̂t Blanchet

Explore authors with similar magnitude of impact

Papers in